The IDEAL framework for machine perfusion in liver transplantation
- PMID: 40523963
- DOI: 10.1038/s41575-025-01085-5
The IDEAL framework for machine perfusion in liver transplantation
Conflict of interest statement
Competing interests: D.N. and C.D.L.C. have received consultancy income from OrganOx for assisting with the design and conduct of previous trials. P.J.F. is a co-founder and shareholder in OrganOx and received consultancy payments as non-executive chief medical officer of the company. R.J.P. has received speaker’s honoraria and travel support paid to the institution by XVIVO and Aferetica. V.E.d.M. has received speaker’s honoraria paid to the institution by Astellas, Chiesi and XVIVO. O.B.v.L., P.D. and G.C.O. declare no competing interests.
References
LinkOut - more resources
Full Text Sources